Evaluation of telomerase activation in head and neck cancer

被引:20
|
作者
Patel, MM
Patel, DD
Parekh, LJ
Raval, GN
Rawal, RM
Bhatavdekar, JM
Patel, BP
Patel, PS [1 ]
机构
[1] Gujarat Canc Soc, Div Res, Biochem Sect, Ahmadabad 380016, Gujarat, India
[2] Gujarat Canc Res Inst, Dept Surg Oncol, Ahmadabad 380016, Gujarat, India
[3] Gujarat Canc Res Inst, Dept Canc Biol, Ahmadabad 380016, Gujarat, India
[4] Maharaja Sayajirao Univ Baroda, Dept Biochem, Baroda 390002, Gujarat, India
关键词
telomerase; head and neck cancer; cancer and precancerous lesions;
D O I
10.1016/S1368-8375(99)00025-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
During replication of the linear chromosomes, telomeres, i.e. the ends of the chromosomes, are not replicated completely by the conventional DNA polymerases. Therefore, normal somatic cells senesce after certain number of cell divisions. Telomerase is a special reverse transcriptase used by most eukaryotes to achieve immortalization. Telomerase activity has been determined in a variety of cancers. However, there are few reports on telomerase activity in head and neck cancer. The etiology of the disease in India is completely different from Western countries. Tobacco consumption is more prevalent in India and the mode of tobacco consumption (e.g. chewing, snuffing, bidi smoking, reverse smoking) is also different. The present study determined telomerase activity in 32 malignant tumour samples of head and neck cancer patients, 11 samples from patients with precancerous/benign lesions and 30 samples of adjacent normal tissues. Telomerase was found to be activated in 80% of the patients with head and neck cancer, 100% of the patients with precancerous/benign lesions and 74% of the adjacent normal tissues. According to the theory of field cancerization, carcinogenic insults (e.g. tobacco) may result into multiple malignant foci. This fact may explain the reason for high telomerase positivity in adjacent normal as well as precancerous/benign tissues. Telomerase activation and the clinical or histopathological characteristics of the head and neck cancer patients were observed to be independent features. This is a preliminary report which has generated a greater interest for in-depth elucidation of the role of telomerase and telomeres in head and neck carcinogenesis in India. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:510 / 515
页数:6
相关论文
共 50 条
  • [1] Clinical usefulness of telomerase activation and telomere length in head and neck cancer
    Patel, MM
    Parekh, LJ
    Jha, FP
    Sainger, RN
    Patel, JB
    Patel, DD
    Shah, PM
    Patel, PS
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2002, 24 (12): : 1060 - 1067
  • [2] Telomerase Activity in Head and Neck Cancer
    Kunicka, Zuzana
    Mucha, Igor
    Fajkus, Jiri
    ANTICANCER RESEARCH, 2008, 28 (5B) : 3125 - 3129
  • [3] Preclinical evaluation of telomerase-specific virotheranostics for human head and neck cancer
    Kurihara, Yuji
    Kojima, Toru
    Shirota, Tatsuo
    Hatori, Masashi
    Urata, Yasuo
    Fujiwara, Toshiyoshi
    Shintani, Satoru
    CANCER RESEARCH, 2009, 69
  • [4] Telomerase activation and telomere length in head and neck cancer in Western India (Gujarat): Institutional experience
    Rakesh, RM
    Sainger, RN
    Shah, PM
    Patel, PS
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 241 - 241
  • [5] Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer
    Yeh, Tsung-Jang
    Luo, Chi-Wen
    Du, Jeng-Shiun
    Huang, Chien-Tzu
    Wang, Min-Hung
    Chuang, Tzer-Ming
    Gau, Yuh-Ching
    Cho, Shih-Feng
    Liu, Yi-Chang
    Hsiao, Hui-Hua
    Chen, Li-Tzong
    Pan, Mei-Ren
    Wang, Hui-Ching
    Moi, Sin-Hua
    BIOMEDICINES, 2023, 11 (03)
  • [6] Telomerase-Specific Virotheranostics for Human Head and Neck Cancer
    Kurihara, Yuji
    Watanabe, Yuichi
    Onimatsu, Hideki
    Kojima, Toru
    Shirota, Tatsuo
    Hatori, Masashi
    Liu, Dong
    Kyo, Satoru
    Mizuguchi, Hiroyuki
    Urata, Yasuo
    Shintani, Satoru
    Fujiwara, Toshiyoshi
    CLINICAL CANCER RESEARCH, 2009, 15 (07) : 2335 - 2343
  • [7] Telomerase inhibition and the future management of head-and-neck cancer
    McCaul, JA
    Gordon, KE
    Clark, LJ
    Parkinson, EK
    LANCET ONCOLOGY, 2002, 3 (05): : 280 - 288
  • [8] Telomerase RNA gene expression in oesophageal and head and neck cancer
    Downey, MG
    Going, JJ
    Stuart, RC
    Keith, WN
    GASTROENTEROLOGY, 1999, 116 (04) : A395 - A395
  • [9] TELOMERASE ACTIVITY AS A DIAGNOSTIC AND PROGNOSTIC FACTOR IN HEAD AND NECK CANCER
    Kunicka, Zuzana
    Mucha, Igor
    Fajkus, Jiri
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3363 - 3363
  • [10] Is telomerase activity a possible marker for the metastasis of head and neck cancer?
    Koscielny, S
    Fiedler, W
    Dahse, R
    Sonntag, J
    Hofmann, SME
    Claussen, U
    Beleites, E
    Ernst, G
    BRITISH JOURNAL OF CANCER, 1998, 77 : 51 - 51